<DOC>
	<DOCNO>NCT00665665</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The aim trial investigate whether drug safe , well tolerated investigate efficacy NNC 0070-0002-0182 treatment obesity . The subject treat drug placebo . This registration cover phase 2 part combine phase 1/phase 2 trial ( phase 1 part trial conduct November 2007 April 2008 ) .</brief_summary>
	<brief_title>Safety , Efficacy , Tolerability Pharmacokinetics NNC 0070-0002-0182 Overweight Obese Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Nutrition Disorders</mesh_term>
	<criteria>Body mass index ( BMI ) 30.039.0 kg/m2 ( obese ) Females consent use double barrier method contraception , postmenopausal old 50 year , total hysterectomy Clinically significant disease Blood pressure great 140/90 mmHg Evidence depression Recent diet attempt , treatment diet drug ( within 3 month ) Liposuction surgery weight loss within last year Evidence eating disorder ( bulimia , binge eat ) Restricted diet ( Kosher , vegetarian ) Smoker history drug alcohol abuse Females childbearing potential : positive pregnancy test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>